Marius Bredell
Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
Riesterer O, Pruschy M, Bender S, Sharma A, Bogowicz M, Tanadini-Lang S, Stieb S, Bertogg K, Weber S, Ikenberg K, Huber G, Schmid S, Bredell M, Veit-Haibach P, Rordorf T, Held U, Glanzmann C, Studer G. Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study. Radiother Oncol 2020; 150:62-69.
12.06.2020Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
12.06.2020Radiother Oncol 2020; 150:62-69
Riesterer Oliver, Pruschy Martin, Bender Sabine, Sharma Ashish, Bogowicz Marta, Tanadini-Lang Stephanie, Stieb Sonja, Bertogg Kaja, Weber Sandra, Ikenberg Kristian, Huber Gerhard, Schmid Stephan, Bredell Marius, Veit-Haibach Patrick, Rordorf Tamara, Held Ulrike, Glanzmann Christoph, Studer Gabriela
Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study.
Bredell M, Rordorf T, Kroiss S, Rücker M, Zweifel D, Rostetter C. Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study. J Oral Maxillofac Surg 2017; 76:775-784.
21.09.2017Denosumab as a Treatment Alternative for Central Giant Cell Granuloma: A Long-Term Retrospective Cohort Study.
21.09.2017J Oral Maxillofac Surg 2017; 76:775-784
Bredell Marius, Rordorf Tamara, Kroiss Sabine, Rücker Martin, Zweifel Daniel Fritz, Rostetter Claudio
Neuer Therapieansatz mit Denosumab bei Riesenzellgranulomen. Ein Fallbeispiel.
Rostetter C, Rordorf T, Essig H, Zweifel D, Schumann P, Rücker M, Bredell M. Neuer Therapieansatz mit Denosumab bei Riesenzellgranulomen. Ein Fallbeispiel. Swiss Dent J 2017; 127:520-521.
01.01.2017Neuer Therapieansatz mit Denosumab bei Riesenzellgranulomen. Ein Fallbeispiel.
01.01.2017Swiss Dent J 2017; 127:520-521
Rostetter Claudio, Rordorf Tamara, Essig Harald, Zweifel Daniel F, Schumann Paul, Rücker Martin, Bredell Marius
Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.
Ernst J, Ikenberg K, Apel B, Schumann D, Huber G, Studer G, Rordorf T, Riesterer O, Rössle M, Korol D, Bredell M. Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue. Oncotarget 2016; 7:76151-76158.
15.11.2016Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.
15.11.2016Oncotarget 2016; 7:76151-76158
Ernst Jutta, Ikenberg Kristian, Apel Barbara, Schumann Desiree M, Huber Gerhard, Studer Gabriela, Rordorf Tamara, Riesterer Oliver, Rössle Matthias, Korol Dimitri, Bredell Marius
IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80.
Brown M, Glanzmann C, Huber G, Bredell M, Rordorf T, Studer G. IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80. Strahlenther Onkol 2016; 192:526-36.
15.06.2016IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80.
15.06.2016Strahlenther Onkol 2016; 192:526-36
Brown Michelle L, Glanzmann Christoph, Huber Gerhard, Bredell Marius, Rordorf Tamara, Studer Gabriela
Late term tolerance in head neck cancer patients irradiated in the IMRT era.
Studer G, Linsenmeier C, Riesterer O, Najafi Y, Brown M, Yousefi B, Bredell M, Huber G, Schmid S, Studer S, Zwahlen R, Rordorf T, Glanzmann C. Late term tolerance in head neck cancer patients irradiated in the IMRT era. Radiat Oncol 2013; 8:259.
05.11.2013Late term tolerance in head neck cancer patients irradiated in the IMRT era.
05.11.2013Radiat Oncol 2013; 8:259
Studer Gabriela, Linsenmeier Claudia, Riesterer Oliver, Najafi Yousef, Brown Michelle L, Yousefi Bita, Bredell Marius, Huber Gerhard, Schmid Stephan, Studer Stephan, Zwahlen Roger A, Rordorf Tamara, Glanzmann Christoph
Follow up after IMRT in oral cavity cancer: update.
Studer G, Brown M, Bredell M, Graetz K, Huber G, Linsenmeier C, Najafi Y, Riesterer O, Rordorf T, Schmid S, Glanzmann C. Follow up after IMRT in oral cavity cancer: update. Radiat Oncol 2012; 7:84.
11.06.2012Follow up after IMRT in oral cavity cancer: update.
11.06.2012Radiat Oncol 2012; 7:84
Studer Gabriela, Brown Michelle L, Bredell Marius, Graetz Klaus W, Huber Gerhard, Linsenmeier Claudia, Najafi Yousef, Riesterer Oliver, Rordorf Tamara, Schmid Stephan, Glanzmann Christoph